Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome : The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients

enthalten in: ISRN pediatrics | 2012

von Gross, O. | Friede, T. | Hilgers, R. | +4